106 results
8-K
EX-3.1
GOSS
Gossamer Bio Inc
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
designed to (x) produce economic benefits and risks that correspond substantially to the ownership of any class or series of shares of the Corporation, (y
8-K
EX-10.1
2d80 bu6t63
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
424B3
budnb 9fl8c
28 Aug 23
Prospectus supplement
4:29pm
S-3
j53wzvbk95aes32
18 Aug 23
Shelf registration
8:41am
S-3ASR
1yqz1prlky0c5brds
17 Aug 23
Automatic shelf registration
4:01pm
8-K
EX-10.1
4lfm30gpmyy
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
PRE 14A
mu216 4u33
17 Apr 23
Preliminary proxy
4:01pm
S-3ASR
e4iyhid
9 Aug 22
Automatic shelf registration
12:00am
8-K
EX-10.1
7ac4vu1evnn qx6nalg
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am